Community-acquired pneumonia and sepsis

Clinics in Chest Medicine

Volumn 26, Issue 1, 2005, Pages 19-28

  Beutz, Michelle A ^a   Abraham, Edward ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CORTICOSTEROID; CORTICOTROPIN; DOBUTAMINE; DOPAMINE; DROTRECOGIN; FLUDROCORTISONE; HYDROCORTISONE; INSULIN; STEROID; VASOACTIVE AGENT;

ARTIFICIAL VENTILATION; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; GASTROINTESTINAL HEMORRHAGE; HOSPITAL INFECTION; HUMAN; HYPERGLYCEMIA; INFECTION RATE; INFECTION RISK; INSULIN TREATMENT; MENTAL DISEASE; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SEPSIS;

EID: 15744368805     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2004.10.015     Document Type: Review

References (51)

1. D.L. Hoyert, E. Arias, and B.L. Smith Deaths: final data for 1999. National vital statistics reports, vol 49, no 8 2001 National Center for Health Statistics Hyattsville (MD) [DHHS publication #(PHS) 2001-1120 PRS 01-0573]
2. C. Brun-Buisson, F. Doyon, and J. Carlet Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units JAMA 274 1995 968 974
3. D.C. Angus, W.T. Linde-Zwirble, and J. Lidicker Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 7 2001 1303 1310
4. D.C. Angus, and R.S. Wax Epidemiology of sepsis: an update Crit Care Med 29 Suppl 2001 S109 S116
5. G.W. Waterer, M.W. Quasney, and R.M. Cantor Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations Am J Respir Crit Care Med 163 2001 1599 1604
6. M. Ruiz, S. Ewig, and A. Torres Severe community-acquired pneumonia: risk factors and epidemiology Am J Respir Crit Care Med 160 1999 923 929
7. A.P. Wheeler, and G.R. Bernard Treating patients with severe sepsis N Engl J Med 340 3 1999 207 214
8. D. Annane, P. Aegerter, and M.C. Jars-Guincestre Current epidemiology of septic shock: the CUB-Rea Network Am J Respir Crit Care Med 168 2003 165 172
9. C. Alberti, C. Brun-Buisson, and H. Burchardi Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study Intensive Care Med 28 2 2001 108 121
10. R.C. Bone, R.A. Balk, and F.B. Cerra ACCP/SCCM Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Chest 101 1992 1644 1655
11. J.L. Vincent Dear SIRS, I'm sorry to say that I don't like you Crit Care Med 25 1997 372 374
12. M.S. Rangel Frausto, D. Pittet, and M. Costigan The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study JAMA 273 1995 117 123
13. I. Salvo, W. De Cian, and M. Musicco The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis, and septic shock Intensive Care Med 21 1995 S244 S249
14. M.M. Levy, M.P. Fink, and J.C. Marshal 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Crit Care Med 31 2003 1250 1256
15. G.S. Martin, D.M. Mannino, and S. Eaton The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 348 16 2003 1546 1554
16. The EPISEPSIS Study Group EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units Intensive Care Med 30 2004 580 588
17. J. Rello, M. Ricart, and B. Mirelis Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes Intensive Care Med 20 1994 94 98
18. S. Harbarth, J. Garbino, and J. Pugin Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis Am J Med 115 2003 529 535
19. C. Brun-Buisson, F. Doyon, and J. Cartlet Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals Am J Respir Crit Care Med 154 1996 617 624
20. T.I. Sorensen, G.G. Nielsen, and P.K. Andersen Genetic and environmental influences and premature death in adult adoptees N Engl J Med 318 1988 727 732
21. R.G. Wunderink, and G.W. Waterer Genetics of sepsis and pneumonia Curr Opin Crit Care 9 2003 384 389
22. C.L. Holmes, J.A. Russell, and K.R. Walley Genetic polymorphisms in sepsis and septic shock Chest 124 2003 1103 1115
23. J.P. Mira, A. Cariou, and F. Grall Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study JAMA 282 1999 561 568
24. N. Riedemann, R.-F. Guo, and P.A. Ward Novel strategies for the treatment of sepsis Nat Med 9 5 2003 517 524
25. R.S. Hotchkiss, and I.E. Karl The pathophysiology and treatment of sepsis N Engl J Med 348 2 2003 138 150
26. R.S. Hotchkiss, P.E. Swanson, and B.D. Freeman Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction Crit Care Med 27 1999 1230 1251
27. R.S. Hotchkiss, K.W. Tinsley, and P.E. Swanson Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans J Immunol 166 2001 6952 6963
28. R.S. Hotchkiss, K.W. Tinsley, and P.E. Swanson Depletion of dendritic cells, but not macrophages, in patients with sepsis J Immunol 168 2002 2493 2500
29. R.E. Voll, M. Herrmann, and E.A. Roth Immunosuppressive effects of apoptotic cells Nature 390 1997 350 351
30. C.M. Coopersmith, P.E. Stromberg, and C.G. Davis Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest Crit Care Med 31 6 2003 1630 1637
31. D.E. Chiumello, G. Pristine, and A. Slutsky Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome Am J Respir Crit Care Med 160 1999 109 116
32. F. Schortgen, L. Bouadma, and M.-L. Joly-Guillou Infectious and inflammatory dissemination are affected by ventilation strategy in rats with unilateral pneumonia Intensive Care Med 30 2004 693 701
33. V.M. Ranieri, F. Giunta, and P.M. Suter Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome JAMA 284 1 2000 43 44
34. C.-Y. Lin, H. Zhang, and K.-C. Cheng Mechanical ventilation may increase susceptibility to the development of bacteremia Crit Care Med 31 5 2003 1429 1434
35. S.B. Yan, J.D. Helterbrand, and D.L. Hartman Low levels of protein C are associated with poor outcomes in severe sepsis Chest 120 2001 915 922
36. J.F. Hesselvik, J. Malm, and B. Dahlback Protein C, protein S, C4b-binding protein in severe infection and septic shock Throm Haemost 65 1991 126 129
37. F. Fourrier, C. Chopin, and J. Goudemand Septic shock, multiple organ failure, and disseminated intravascular coagulation: compared patterns of antithrombin III, protein C, and protein S deficiencies Chest 101 1992 816 823
38. F.B. Taylor Jr, A. Chang, and C.T. Esmon Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon J Clin Invest 79 1987 918 925
39. G.R. Bernard, J.-L. Vincent, and P.-F. Laterre Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 2001 699 709
40. J.-F. Dhainaut, P.-F. Laterre, and J.M. Janes Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial Intensive Care Med 29 2003 894 903
41. J.-L. Vincent, E. Abraham, and D. Annane Reducing mortality in sepsis: new directions Crit Care 6 2002 S1 S18
42. L. Cronin, D.J. Cook, and J. Carlet Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis Crit Care Med 23 1995 1430 1439
43. R. Lefering, and E.A. Neugeauer Steroid controversy in sepsis and septic shock: a meta-analysis Crit Care Med 23 1995 1294 1303
44. P.M. Rothwell, Z.F. Udwadia, and P.G. Lawler Cortisol response to corticotropin and survival in septic shock Lancet 337 1991 582 583
45. D. Annane, V. Sebille, and G. Troche A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin JAMA 283 2000 1038 1045
46. D. Annane, V. Sebille, and C. Charpentier Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock JAMA 288 2002 862 871
47. E. Abraham, and T. Evans Corticosteroids and septic shock JAMA 288 2002 886 887
48. K.C. McCowen, A. Malhotra, and B.R. Bistrian Stress-induced hyperglycemia Crit Care Clin 17 2001 107 124
49. G. Van den Berghe, P. Wouters, and F. Weekers Intensive insulin therapy in critically ill patients N Engl J Med 345 2001 1359 1367
50. G. Van den Berghe, P. Wouters, and R. Bouillon Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control Crit Care Med 31 2 2003 359 366
51. E. Rivers, B. Nguyen, and S. Havstad Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 19 2001 1368 1377